Epigenetic and Microbiota Modifications

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 10, 2019

Primary Completion Date

October 17, 2020

Study Completion Date

June 30, 2022

Conditions
Diabetes type2Obesity
Interventions
DIETARY_SUPPLEMENT

Lactobacillus fermentum D3

Lactobacillus fermentum D3 in a white, gelatin capsule (orally), with lyophilized L. fermentum D3 without preservatives, sugars, or additives.

BIOLOGICAL

Fecal microbiota transplant (FMT)

Fecal microbiota transplant (FMT) in a green, gelatin capsule (orally), with lyophilized fecal material.

DRUG

Placebo

Placebo in a white, gelatin capsule (orally), with powder milk

Trial Locations (1)

29010

Hospital Universitario Virgen de la Victoria, Málaga

All Listed Sponsors
lead

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

OTHER

NCT05076656 - Epigenetic and Microbiota Modifications | Biotech Hunter | Biotech Hunter